Kiadis Pharma

Kiadis Pharma is a clinical stage biopharmaceutical company focused on cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders

  • Kiadis Pharma floated on Euronext Amsterdam and Euronext Brussels
  • Proceeds of the IPO will be used to advance the clinical development of the lead products
  • Kempen & Co acted as Sole Global Coordinator and Joint Bookrunner in the transaction
     
Disclaimer Kempen Privacy statement Kempen Disclaimer Kempen & Co Privacy statement Kempen & Co Statement under the UK Modern Slavery Act Cookie statement & settings
Kempen & Co is a trade name of Van Lanschot Kempen Wealth Management NV. Both Van Lanschot Kempen Wealth Management NV and Kempen Capital Management NV are part of Van Lanschot Kempen NV